{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T07:01:51Z","timestamp":1784012511625,"version":"3.55.0"},"publisher-location":"New York, NY","reference-count":35,"publisher":"Springer US","isbn-type":[{"value":"9781071636619","type":"print"},{"value":"9781071636626","type":"electronic"}],"license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024]]},"DOI":"10.1007\/978-1-0716-3662-6_24","type":"book-chapter","created":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T06:03:10Z","timestamp":1709272990000},"page":"329-336","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Enzyme Inhibition Assays for Monoamine Oxidase"],"prefix":"10.1007","author":[{"given":"Bijo","family":"Mathew","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong Min","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Della Grace Thomas","family":"Parambi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachithra Thazhathuveedu","family":"Sudevan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,2]]},"reference":[{"key":"24_CR1","first-page":"25","volume":"51","author":"JC Shih","year":"1999","unstructured":"Shih JC, Chen K, Ridd MJ (1999) Role of MAO A and B in neurotransmitter metabolism and behavior. Pol J Pharmacol 51:25\u201329","journal-title":"Pol J Pharmacol"},{"key":"24_CR2","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.3892\/mmr.2014.2040","volume":"9","author":"Z Cai","year":"2014","unstructured":"Cai Z (2014) Monoamine oxidase inhibitors: promising therapeutic agents for Alzheimer\u2019s disease (Review). Mol Med Rep 9:1533\u20131541","journal-title":"Mol Med Rep"},{"key":"24_CR3","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1016\/j.addr.2008.06.002","volume":"60","author":"M Bortolato","year":"2008","unstructured":"Bortolato M, Chen K, Shih JC (2008) Monoamine oxidase inactivation: from pathophysiology to therapeutics. Adv Drug Deliv Rev 60:1527\u20131533","journal-title":"Adv Drug Deliv Rev"},{"key":"24_CR4","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.abb.2007.05.006","volume":"464","author":"DE Edmondson","year":"2007","unstructured":"Edmondson DE, Binda C, Mattevi A (2007) Structural insights into the mechanism of amine oxidation by monoamine oxidases A and B. Arch Biochem Biophys 464:269\u2013176","journal-title":"Arch Biochem Biophys"},{"key":"24_CR5","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/BF02251224","volume":"10","author":"T Brannan","year":"1995","unstructured":"Brannan T, Prikhojan A, Mart\u00ednez-Tica J, Yahr MD (1995) In vivo comparison of the effects of inhibition of MAO-A versus MAO-B on striatal L-DOPA and dopamine metabolism. J Neural Transm Park Dis Dement Sect 10:79\u201389","journal-title":"J Neural Transm Park Dis Dement Sect"},{"key":"24_CR6","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1146\/annurev.neuro.22.1.197","volume":"22","author":"JC Shih","year":"1999","unstructured":"Shih JC, Chen K, Ridd MJ (1999) Monoamine oxidase: from genes to behavior. Annu Rev Neurosci 22:197\u2013217","journal-title":"Annu Rev Neurosci"},{"key":"24_CR7","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/nsb732","volume":"9","author":"C Binda","year":"2002","unstructured":"Binda C, Newton-Vinson P, Hub\u00e1lek F, Edmondson DE, Mattevi A (2002) Structure of human monoamine oxidase B, a drug target for the treatment of neurological disorders. Nat Struct Biol 9:22\u201326","journal-title":"Nat Struct Biol"},{"key":"24_CR8","doi-asserted-by":"publisher","first-page":"S62","DOI":"10.1212\/01.WNL.0000095215.97585.59","volume":"61","author":"N Castagnoli","year":"2003","unstructured":"Castagnoli N, Petzer JP, Steyn S, Castagnoli K, Chen J-F, Schwarzschild MA, Van der Schyf CJ (2003) Monoamine oxidase B inhibition and neuroprotection: studies on selective adenosine A2A receptor antagonists. Neurology 61:S62\u2013S68","journal-title":"Neurology"},{"key":"24_CR9","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1038\/jcbfm.2013.19","volume":"33","author":"J Tong","year":"2013","unstructured":"Tong J, Meyer JH, Furukawa Y, Boileau I, Chang L-J, Wilson AA, Houle S, Kish SJ (2013) Distribution of monoamine oxidase proteins in human brain: implications for brain imaging studies. J Cereb Blood Flow Metab 33:863\u2013871","journal-title":"J Cereb Blood Flow Metab"},{"key":"24_CR10","doi-asserted-by":"publisher","first-page":"S287","DOI":"10.1038\/sj.bjp.0706464","volume":"147","author":"MB Youdim","year":"2006","unstructured":"Youdim MB, Bakhle Y (2006) Monoamine oxidase: isoforms and inhibitors in Parkinson\u2019s disease and depressive illness. Br J Pharmacol 147:S287\u2013S296","journal-title":"Br J Pharmacol"},{"key":"24_CR11","doi-asserted-by":"publisher","first-page":"3841","DOI":"10.5012\/bkcs.2012.33.11.3841","volume":"33","author":"G Jo","year":"2012","unstructured":"Jo G, Sung SH, Lee Y, Kim B-G, Yoon J, Lee HO et al (2012) Discovery of monoamine oxidase A inhibitors derived from in silico docking. Bull Korean Chem Soc 33:3841\u20133844","journal-title":"Bull Korean Chem Soc"},{"key":"24_CR12","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.ejmech.2017.01.011","volume":"127","author":"NT Tzvetkov","year":"2017","unstructured":"Tzvetkov NT, Stammler H-G, Neumann B, Hristova S, Antonov L, Gastreich M (2017) Crystal structures, binding interactions, and ADME evaluation of brain penetrant N-substituted indazole-5-carboxamides as subnanomolar, selective monoamine oxidase B and dual MAO-A\/B inhibitors. Eur J Med Chem 127:470\u2013492","journal-title":"Eur J Med Chem"},{"key":"24_CR13","first-page":"1032","volume":"52","author":"HG Brunner","year":"1993","unstructured":"Brunner HG, Nelen MR, Van Zandvoort P, Abeling NG, Van Gennip AH, Wolters EC, Kuiper MA, Ropers HH, Van Oost BA (1993) X-linked borderline mental retardation with prominent behavioral disturbance: phenotype, genetic localization, and evidence for disturbed monoamine metabolism. Am J Hum Genet 52:1032\u20131039","journal-title":"Am J Hum Genet"},{"key":"24_CR14","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1111\/j.1399-0004.2010.01471.x","volume":"79","author":"IL Cohen","year":"2011","unstructured":"Cohen IL, Liu X, Lewis M, Chudley A, Forster-Gibson C, Gonzalez M, Jenkins EE, Brown WT, Holden JJ (2011) Autism severity is associated with child and maternal MAOA genotypes. Clin Genet 79:355\u2013362","journal-title":"Clin Genet"},{"key":"24_CR15","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1001\/archpsyc.63.11.1209","volume":"63","author":"JH Meyer","year":"2006","unstructured":"Meyer JH, Ginovart N, Boovariwala A, Sagrati S, Hussey D, Garcia A, Young T, Praschak-Rieder N, Wilson AA, Houle S (2006) Elevated monoamine oxidase a level in the brain: an explanation for the monoamine imbalance of major depression. Arch Gen Psychiatry 63:1209\u20131216","journal-title":"Arch Gen Psychiatry"},{"key":"24_CR16","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/0306-4522(94)90311-5","volume":"62","author":"J Saura","year":"1994","unstructured":"Saura J, Luque J, Cesura A, Da Prada M, Chan-Palay V, Huber G, L\u00f6ffler J, Richards JG (1994) Increased monoamine oxidase B activity in plaque-associated astrocytes of Alzheimer brains revealed by quantitative enzyme radioautography. Neuroscience 62:15\u201330","journal-title":"Neuroscience"},{"key":"24_CR17","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1007\/s12640-009-9032-2","volume":"16","author":"JK Mallajosyula","year":"2009","unstructured":"Mallajosyula JK, Chinta SJ, Rajagopalan S, Nicholls DG, Andersen JK (2009) Metabolic control analysis in a cellular model of elevated MAO-B: relevance to Parkinson\u2019s disease. Neurotox Res 16:186\u2013193","journal-title":"Neurotox Res"},{"key":"24_CR18","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/S0161-813X(03)00106-2","volume":"25","author":"P Riederer","year":"2004","unstructured":"Riederer P, Danielczyk W, Gr\u00fcnblatt E (2004) Monoamine oxidase-B inhibition in Alzheimer\u2019s disease. Neurotoxicology 25:271\u2013277","journal-title":"Neurotoxicology"},{"key":"24_CR19","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/S0161-813X(03)00097-4","volume":"25","author":"M Yamada","year":"2004","unstructured":"Yamada M, Yasuhara H (2004) Clinical pharmacology of MAO inhibitors: safety and future. Neurotoxicology 25:215\u2013221","journal-title":"Neurotoxicology"},{"key":"24_CR20","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.2174\/0929867043364775","volume":"11","author":"P Riederer","year":"2004","unstructured":"Riederer P, Lachenmayer L, Laux G (2004) Clinical applications of MAO inhibitors. Curr Med Chem 11:2033\u20132043","journal-title":"Curr Med Chem"},{"key":"24_CR21","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.psychres.2005.07.012","volume":"141","author":"V Henkel","year":"2006","unstructured":"Henkel V, Mergl R, Allgaier A-K, Kohnen R, M\u00f6ller H-J, Hegerl U (2006) Treatment of depression with atypical features: a meta-analytic approach. Psychiatry Res 141:89\u2013101","journal-title":"Psychiatry Res"},{"key":"24_CR22","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1750-1326-2-13","volume":"2","author":"SE Lakhan","year":"2007","unstructured":"Lakhan SE (2007) From a Parkinson\u2019s disease expert: rasagiline and the future of therapy. Mol Neurodegener 2:13","journal-title":"Mol Neurodegener"},{"key":"24_CR23","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1038\/npp.2014.214","volume":"40","author":"JS Fowler","year":"2015","unstructured":"Fowler JS, Logan J, Volkow ND, Shumay E, Mccall-Perez F, Jayne M, Wang GJ, Alexoff DL, Apelskog-Torres K, Hubbard B, Carter P, King P, Fahn S, Gilmor M, Telang F, Shea C, Xu Y, Muench L (2015) Evidence that formulations of the selective MAO-B inhibitor, selegiline, which bypass first-pass metabolism, also inhibit MAO-A in the human brain. Neuropsychopharmacology 40:650\u2013657","journal-title":"Neuropsychopharmacology"},{"key":"24_CR24","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1007\/s40265-015-0389-7","volume":"75","author":"ED Deeks","year":"2015","unstructured":"Deeks ED (2015) Safinamide: first global approval. Drugs 75:705\u2013711","journal-title":"Drugs"},{"key":"24_CR25","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1124\/jpet.117.241653","volume":"362","author":"E Borroni","year":"2017","unstructured":"Borroni E, Bohrmann B, Grueninger F, Prinssen E, Nave S, Loetscher H, Chinta SJ, Rajagopalan S, Rane A, Siddiqui A, Ellenbroek B, Messer J, P\u00e4hler A, Andersen JK, Wyler R, Cesura AM (2017) Sembragiline: a novel, selective monoamine oxidase type B inhibitor for the treatment of Alzheimer\u2019s disease. J Pharmacol Exp Ther 362:413\u2013423","journal-title":"J Pharmacol Exp Ther"},{"key":"24_CR26","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.ejmech.2018.11.009","volume":"162","author":"NT Tzvetkov","year":"2019","unstructured":"Tzvetkov NT, Stammler H-G, Hristova S, Atanasov AG, Antonov L (2019) (Pyrrolo-pyridin-5-yl) benzamides: BBB permeable monoamine oxidase B inhibitors with neuroprotective effect on cortical neurons. Eur J Med Chem 162:793\u2013809","journal-title":"Eur J Med Chem"},{"key":"24_CR27","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1021\/jm031087c","volume":"47","author":"C Binda","year":"2004","unstructured":"Binda C, Hub\u00e1lek F, Li M, Herzig Y, Sterling J, Edmondson DE, Mattevi A (2004) Crystal structures of monoamine oxidase B in complex with four inhibitors of the N-propargylaminoindan class. J Med Chem 47:1767\u20131774","journal-title":"J Med Chem"},{"key":"24_CR28","doi-asserted-by":"publisher","first-page":"5848","DOI":"10.1021\/jm070677y","volume":"50","author":"C Binda","year":"2007","unstructured":"Binda C, Wang J, Pisani L, Caccia C, Carotti A, Salvati P, Edmondson DE, Mattevi A (2007) Structures of human monoamine oxidase B complexes with selective noncovalent inhibitors: safinamide and coumarin analogs. J Med Chem 50:5848\u20135852","journal-title":"J Med Chem"},{"key":"24_CR29","doi-asserted-by":"publisher","first-page":"12684","DOI":"10.1073\/pnas.0505975102","volume":"102","author":"L De Colibus","year":"2005","unstructured":"De Colibus L, Li M, Binda C, Lustig A, Edmondson DE, Mattevi A (2005) Three-dimensional structure of human monoamine oxidase A (MAO A): relation to the structures of rat MAO A and human MAO B. Proc Natl Acad Sci U S A 102:12684\u201312689","journal-title":"Proc Natl Acad Sci U S A"},{"key":"24_CR30","doi-asserted-by":"publisher","first-page":"5739","DOI":"10.1073\/pnas.0710626105","volume":"105","author":"S-Y Son","year":"2008","unstructured":"Son S-Y, Ma J, Kondou Y, Yoshimura M, Yamashita E, Tsukihara T (2008) Structure of human monoamine oxidase A at 2.2-\u00c5resolution: the control of opening the entry for substrates\/inhibitors. Proc Natl Acad Sci U S A 105:5739\u20135744","journal-title":"Proc Natl Acad Sci U S A"},{"key":"24_CR31","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.ijbiomac.2020.02.144","volume":"151","author":"JM Oh","year":"2020","unstructured":"Oh JM, Jang HJ, Kim WJ, Kang MG, Baek SC, Lee JP, Park D, Oh SR, Kim H (2020) Calycosin and 8-O-methylretusin isolated from Maackia amurensis as potent and selective reversible inhibitors of human monoamine oxidase-B. Int J Biol Macromol 151:441\u2013448","journal-title":"Int J Biol Macromol"},{"issue":"4","key":"24_CR32","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1104\/pp.117.4.1363","volume":"117","author":"A Padiglia","year":"1998","unstructured":"Padiglia A, Medda R, Lorrai A, Murgia B, Pedersen JZ, Finazzi Agr\u00f3 A, Floris G (1998) Characterization of euphorbia characias latex amine oxidase. Plant Physiol 117(4):1363\u20131371","journal-title":"Plant Physiol"},{"key":"24_CR33","unstructured":"www.webbook.nist.gov\/chemistry"},{"issue":"5","key":"24_CR34","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1016\/j.bmcl.2017.01.085","volume":"27","author":"HW Lee","year":"2017","unstructured":"Lee HW, Ryu HW, Kang MG, Park D, Oh SR, Kim H (2017) Selective inhibition of monoamine oxidase A by purpurin, an anthraquinone. Bioorg Med Chem Lett 27(5):1136\u20131140","journal-title":"Bioorg Med Chem Lett"},{"issue":"19","key":"24_CR35","doi-asserted-by":"publisher","first-page":"4714","DOI":"10.1016\/j.bmcl.2016.08.044","volume":"26","author":"HW Lee","year":"2016","unstructured":"Lee HW, Ryu HW, Kang MG, Park D, Oh SR, Kim H (2016) Potent selective monoamine oxidase B inhibition by maackiain, a pterocarpan from the roots of Sophora flavescens. Bioorg Med Chem Lett 26(19):4714\u20134719","journal-title":"Bioorg Med Chem Lett"}],"container-title":["Methods in Molecular Biology","Neuroprotection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-3662-6_24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T06:22:44Z","timestamp":1709274164000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-3662-6_24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"ISBN":["9781071636619","9781071636626"],"references-count":35,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-3662-6_24","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024]]},"assertion":[{"value":"2 March 2024","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}